You have 9 free searches left this month | for more free features.

Tranilast

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Nasopharyngeal Carcinoma, Recurrent Cancer Trial in Guangzhou (Tranilast)

Recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent Cancer
  • Tranilast
  • Guangzhou, Guangdong, China
    Southern medical university
Nov 15, 2022

NLRP3, hsCRP, Percutaneous Coronary Intervention Trial in Wuhan (Colchicine, Tranilast, Oridonin)

Recruiting
  • NLRP3
  • +2 more
  • Wuhan, Hubei, China
  • +1 more
Jul 22, 2022

Cryopyrin-Associated Periodic Syndromes Trial in Beijing (Tranilast)

Recruiting
  • Cryopyrin-Associated Periodic Syndromes
  • Tranilast
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 1, 2019

Hypertrophic Scar Trial in Islamabad, Rawalpindi (Microneedling, Percutaneous Collagen Induction)

Recruiting
  • Hypertrophic Scar
  • Microneedling
  • Percutaneous Collagen Induction
  • Islamabad, Federal, Pakistan
  • +1 more
Nov 3, 2021

Sarcoidosis Trial (Tranilast)

Unknown status
  • Sarcoidosis
  • Tranilast
  • (no location specified)
May 6, 2018

Scleredema Adultorum Trial (Tranilast)

Unknown status
  • Scleredema Adultorum
  • Tranilast
  • (no location specified)
Apr 19, 2018

Mucinoses Trial (Tranilast)

Not yet recruiting
  • Mucinoses
  • Tranilast
  • (no location specified)
Apr 1, 2018

Rheumatoid Arthritis Trial (Tranilast, Placebo comparator)

Withdrawn
  • Rheumatoid Arthritis
  • Tranilast
  • Placebo comparator
  • (no location specified)
May 27, 2015

Osteoarthritis of the Hands Trial (A/B, Placebo, B/A)

Unknown status
  • Osteoarthritis of the Hands
  • (no location specified)
Jun 25, 2015

Coronary Occlusions Trial in Canada, United States (Cypher sirolimus eluting coronary stent)

Completed
  • Coronary Occlusions
  • Cypher sirolimus eluting coronary stent
  • La Jolla, California
  • +15 more
Sep 11, 2014

Allergic Conjunctivitis Trial (Olopatadine 0.1%, Tranilast 0.5%, Placebo (Olopatadine))

Completed
  • Allergic Conjunctivitis
  • Olopatadine 0.1%
  • +3 more
  • (no location specified)
May 29, 2012

Pterygium Trial in Sao Jose do Rio Preto (Tranilast, and Tissucol, Beriplast P)

Completed
  • Pterygium
  • Tranilast, and Tissucol
  • Beriplast P
  • Sao Jose do Rio Preto, Sao Paulo, Brazil
    Hospital de Base/FAMERP
Apr 16, 2012

Gout, Hyperuricemia Trial in Honolulu, Evansville, Dallas (Tranilast, Febuxostat, Combination - Tranilast and Febuxostat)

Completed
  • Gout
  • Hyperuricemia
  • Tranilast
  • +2 more
  • Honolulu, Hawaii
  • +2 more
Jan 5, 2011

Gout, Hyperuricemia Trial in Honolulu, Evansville, Dallas (Tranilast, Allopurinol, Combination - Tranilast and Allopurinol)

Completed
  • Gout
  • Hyperuricemia
  • Tranilast
  • +4 more
  • Honolulu, Hawaii
  • +2 more
Jan 5, 2011

Active Rheumatoid Arthritis Trial in Worldwide (Tranilast, Placebo)

Completed
  • Active Rheumatoid Arthritis
  • Tranilast
  • Placebo
  • Mesa, Arizona
  • +31 more
Jan 5, 2011

Moderate to Severe Gout, Hyperuricemia Trial in United States (Combination 400, Allopurinol, Combination 600)

Completed
  • Moderate to Severe Gout
  • Hyperuricemia
  • Combination 400
  • +2 more
  • La Jolla, California
  • +23 more
Jan 5, 2011

In-stent Restenosis in Patent Previous Bare Metal Stent

Completed
  • In-stent Coronary Artery Restenosis
    • Haifa, Israel
      Rambam Medical Center
    Feb 14, 2011